UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 88

Sortiert nach

Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease

Brain (London, England : 1878), 2015-09, Vol.138 (Pt 9), p.2687-2700

2015

Volltextzugriff (PDF)

Diurnal and seasonal variation of the brain serotonin system in healthy male subjects

NeuroImage (Orlando, Fla.), 2015-05, Vol.112, p.225-231

2015

Volltextzugriff (PDF)

Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11C]PBR28 and Machine Learning Analysis

Movement disorders, 2022-01, Vol.37 (1), p.119-129

2022

Volltextzugriff (PDF)

Brain exposure of the ATM inhibitor AZD1390 in humans-a positron emission tomography study

Neuro-oncology (Charlottesville, Va.), 2021-04, Vol.23 (4), p.687-696

2021

Volltextzugriff (PDF)

The pro-psychotic metabotropic glutamate receptor compounds fenobam and AZD9272 share binding sites with monoamine oxidase-B inhibitors in humans

Neuropharmacology, 2020-01, Vol.162, p.107809, Article 107809

2020

Volltextzugriff (PDF)

A positron emission tomography study in healthy volunteers to estimate mGluR5 receptor occupancy of AZD2066 — Estimating occupancy in the absence of a reference region

NeuroImage (Orlando, Fla.), 2013-11, Vol.82, p.160-169

2013

Volltextzugriff (PDF)

Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding

Brain (London, England : 1878), 2006-08, Vol.129 (8), p.2017-2028

2006

Volltextzugriff (PDF)

Brain exposure of osimertinib in patients with epidermal growth factor receptor mutation non‐small cell lung cancer and brain metastases: A positron emission tomography and magnetic resonance imaging study

Clinical and translational science, 2023-06, Vol.16 (6), p.955-965

2023

Volltextzugriff (PDF)

Nigrostriatal dopamine transporter availability in early Parkinson's disease

Movement disorders, 2018-04, Vol.33 (4), p.592-599

2018

Volltextzugriff (PDF)

Detection of amyloid in Alzheimer’s disease with positron emission tomography using [11C]AZD2184

European journal of nuclear medicine and molecular imaging, 2009-11, Vol.36 (11), p.1859-1863

2009

Volltextzugriff (PDF)

Quantification of Blood Flow-Dependent Component in Estimates of Beta-Amyloid Load Obtained Using Quasi-Steady-State Standardized Uptake Value Ratio

Journal of cerebral blood flow and metabolism, 2015-09, Vol.35 (9), p.1485-1493

2015

Volltextzugriff (PDF)

Kinetic analysis and test-retest variability of the radioligand [11C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects

EJNMMI research, 2012-04, Vol.2 (1), p.15-15

2012

Volltextzugriff (PDF)

Pulmonary PET imaging confirms preferential lung target occupancy of an inhaled bronchodilator

EJNMMI research, 2019-01, Vol.9 (1), p.9-10, Article 9

2019

Volltextzugriff (PDF)

PET imaging of [11C]PBR28 in Parkinson’s disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding

European journal of nuclear medicine and molecular imaging, 2019-02, Vol.46 (2), p.367-375

2019

Volltextzugriff (PDF)

Glia Imaging Shows Clinical Utility in Differentiating Parkinson's Disease from Multiple System Atrophy

Movement disorders, 2022-08, Vol.37 (8), p.1776-1778

2022

Volltextzugriff (PDF)

Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: Preliminary comparative PET studies with [11 C]vinpocetine and [11 C]PK11195 in patients

Journal of the neurological sciences, 2008-01, Vol.264 (1), p.9-17

2008

Volltextzugriff (PDF)

Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer’s disease patients

European journal of nuclear medicine and molecular imaging, 2013, Vol.40 (4), p.580-593

2013

Volltextzugriff (PDF)

Simplified quantification of [18F]FE-PE2I PET in Parkinson’s disease: Discriminative power, test–retest reliability and longitudinal validity during early peak and late pseudo-equilibrium

Journal of cerebral blood flow and metabolism, 2021-06, Vol.41 (6), p.1291-1300

2021

Volltextzugriff (PDF)

Dose-dependent binding of AZD3783 to brain 5-HT1B receptors in non-human primates and human subjects: a positron emission tomography study with [11C]AZ10419369

Psychopharmacology, 2011-02, Vol.213 (2-3), p.533-545

2011

Volltextzugriff (PDF)

Decreased 5‐HT1A binding in mild Alzheimer's disease—A positron emission tomography study

Synapse (New York, N.Y.), 2022-06, Vol.76 (7-8), p.e22235-n/a

2022

Volltextzugriff (PDF)

Radiosynthesis of the candidate β-amyloid radioligand [11C]AZD2184: Positron emission tomography examination and metabolite analysis in cynomolgus monkeys

Synapse (New York, N.Y.), 2010-10, Vol.64 (10), p.733-741

2010

Volltextzugriff (PDF)

High Contrast PET Imaging of Subcortical and Allocortical Amyloid-β in Early Alzheimer's Disease Using [11C]AZD2184

Journal of Alzheimer's disease, 2024-01, Vol.98 (4), p.1391

2024

Volltextzugriff (PDF)

[11C]PBB3 binding in Aβ(–) or Aβ(+) corticobasal syndrome

Synapse (New York, N.Y.), 2023-07, Vol.77 (4), p.e22269-n/a

2023

Volltextzugriff (PDF)

Serotonin 1B receptor density mapping of the human brainstem using positron emission tomography and autoradiography

Journal of cerebral blood flow and metabolism, 2022-04, Vol.42 (4), p.630-641

2022

Volltextzugriff (PDF)

Reliability of volumetric and surface-based normalisation and smoothing techniques for PET analysis of the cortex: A test-retest analysis using [11C]SCH-23390

NeuroImage (Orlando, Fla.), 2017-07, Vol.155, p.344-353

2017

Volltextzugriff (PDF)

1 – 25 von 88

Suche als RSS-Feed

Aktive Filter

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(87)
Dissertationen
(1)

Sprache

Japanisch
(10)
Ungarisch
(2)

Erscheinungsjahr

n.n

Thema

Medicin Och Hälsovetenskap
(53)
Life Sciences & Biomedicine
(43)
Science & Technology
(43)
Humans
(38)
Neurosciences & Neurology
(29)
Male
(27)
Neurosciences
(27)
Positron Emission Tomography
(26)
Brain - Diagnostic Imaging
(24)
Adult
(22)
Radiology, Nuclear Medicine & Medical Imaging
(21)
Positron-Emission Tomography
(20)
Brain
(18)
Brain - Metabolism
(15)
Female
(14)
Middle Aged
(14)
Neuroimaging
(14)
Alzheimer's Disease
(13)
Pet
(13)
Positron-Emission Tomography - Methods
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease

Diurnal and seasonal variation of the brain serotonin system in healthy male subjects

Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11C]PBR28 and Machine Learning Analysis

Brain exposure of the ATM inhibitor AZD1390 in humans-a positron emission tomography study

The pro-psychotic metabotropic glutamate receptor compounds fenobam and AZD9272 share binding sites with monoamine oxidase-B inhibitors in humans

A positron emission tomography study in healthy volunteers to estimate mGluR5 receptor occupancy of AZD2066 — Estimating occupancy in the absence of a reference region

Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding

Brain exposure of osimertinib in patients with epidermal growth factor receptor mutation non‐small cell lung cancer and brain metastases: A positron emission tomography and magnetic resonance imaging study

Nigrostriatal dopamine transporter availability in early Parkinson's disease

Detection of amyloid in Alzheimer’s disease with positron emission tomography using [11C]AZD2184

Quantification of Blood Flow-Dependent Component in Estimates of Beta-Amyloid Load Obtained Using Quasi-Steady-State Standardized Uptake Value Ratio

Kinetic analysis and test-retest variability of the radioligand [11C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects

Pulmonary PET imaging confirms preferential lung target occupancy of an inhaled bronchodilator

PET imaging of [11C]PBR28 in Parkinson’s disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding

Glia Imaging Shows Clinical Utility in Differentiating Parkinson's Disease from Multiple System Atrophy

Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: Preliminary comparative PET studies with [11 C]vinpocetine and [11 C]PK11195 in patients

Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer’s disease patients

Simplified quantification of [18F]FE-PE2I PET in Parkinson’s disease: Discriminative power, test–retest reliability and longitudinal validity during early peak and late pseudo-equilibrium

Dose-dependent binding of AZD3783 to brain 5-HT1B receptors in non-human primates and human subjects: a positron emission tomography study with [11C]AZ10419369

Decreased 5‐HT1A binding in mild Alzheimer's disease—A positron emission tomography study

Radiosynthesis of the candidate β-amyloid radioligand [11C]AZD2184: Positron emission tomography examination and metabolite analysis in cynomolgus monkeys

High Contrast PET Imaging of Subcortical and Allocortical Amyloid-β in Early Alzheimer's Disease Using [11C]AZD2184

[11C]PBB3 binding in Aβ(–) or Aβ(+) corticobasal syndrome

Serotonin 1B receptor density mapping of the human brainstem using positron emission tomography and autoradiography

Reliability of volumetric and surface-based normalisation and smoothing techniques for PET analysis of the cortex: A test-retest analysis using [11C]SCH-23390

Aktive Filter

Suchergebnisse filtern